Literature DB >> 6409238

Improved tumour localisation using indium-111 labelled antibodies.

D S Fairweather, A R Bradwell, P W Dykes, A T Vaughan, S F Watson-James, S Chandler.   

Abstract

Immunoglobulin G (IgG) antibodies to carcinoembryonic antigen (CEA) were labelled with radioactive indium (111In) or iodine (131I) and a comparison made of their value in locating CEA producing tumours. Eleven patients given 111In-anti-CEA had 31 tumours as judged by a combination of all techniques. Of these, 28 were detected by 111In-anti-CEA and 26 by conventional clinical techniques. Five of the patients also received 131I-anti-CEA. These patients had 15 tumour areas. Thirteen were detected by 111In and eight by 131I. 111In also produced a better signal to noise ratio in the scans and thereby showed lesions with greater certainty. In addition, the 111In isotope continued to accumulate in the tumour areas for considerably longer than 131I. Absorbed doses (whole body) were similar for both isotopes. The results show that antibody scanning is greatly improved by using 111In as the radiolabel in place of 131I and should allow the detection of smaller or deeper lesions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409238      PMCID: PMC1548673          DOI: 10.1136/bmj.287.6386.167

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  A technique for the absolute measurement of activity using a gamma camera and computer.

Authors:  J S Fleming
Journal:  Phys Med Biol       Date:  1979-01       Impact factor: 3.609

2.  Radioimmune assay of carcinoembryonic antigen.

Authors:  M L Egan; J T Lautenschleger; J E Coligan; C W Todd
Journal:  Immunochemistry       Date:  1972-03

3.  Covalent attachment of chelating groups to macromolecules.

Authors:  G E Krejcarek; K L Tucker
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

4.  Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA.

Authors:  M W Sundberg; C F Meares; D A Goodwin; C I Diamanti
Journal:  J Med Chem       Date:  1974-12       Impact factor: 7.446

5.  Radiolabeling of antibodies.

Authors:  W C Eckelman; C H Paik; R C Reba
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

6.  Gallium-68 labeling of albumin and albumin microspheres.

Authors:  S J Wagner; M J Welch
Journal:  J Nucl Med       Date:  1979-05       Impact factor: 10.057

7.  Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.

Authors:  A K Halsall; D S Fairweather; A R Bradwell; J C Blackburn; P W Dykes; A Howell; A Reeder; K R Hine
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-10

8.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

Authors:  D M Goldenberg; F DeLand; E Kim; S Bennett; F J Primus; J R van Nagell; N Estes; P DeSimone; P Rayburn
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

9.  Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning.

Authors:  S D Rockoff; D J Goodenough; K R McIntire
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

10.  Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid.

Authors:  B A Khaw; F T Fallon; H W Strauss; E Haber
Journal:  Science       Date:  1980-07-11       Impact factor: 47.728

View more
  19 in total

1.  A comparative distribution study of 111In-labeled DTPA and TTHA monoclonal antibody conjugates in a choriocarcinoma xenograft model.

Authors:  R G Buckley; P Barnett; F Searle; R Pedley; J A Boden
Journal:  Eur J Nucl Med       Date:  1986

2.  Colitis associated with ibuprofen.

Authors:  J Hollingworth
Journal:  BMJ       Date:  1991-01-05

3.  Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs.

Authors:  J Lang; A B Price; A J Levi; M Burke; J M Gumpel; I Bjarnason
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

4.  The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M K Birch
Journal:  Eur J Nucl Med       Date:  1985

5.  Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1985

6.  Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies.

Authors:  A C Perkins; M V Pimm
Journal:  Eur J Nucl Med       Date:  1985

7.  Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.

Authors:  A Chetanneau; P A Lehur; D Ripoche; P Peltier; J C Saccavini; J P Vuillez; N Tournemaine; P Thedrez; J F Chatal
Journal:  Eur J Nucl Med       Date:  1989

8.  Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2).

Authors:  P C Jackson; E M Pitcher; J O Davies; E R Davies; C S Sadowski; G E Staddon; G M Stirrat; C A Sunderland
Journal:  Eur J Nucl Med       Date:  1985

Review 9.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.

Authors:  C Curtet; J P Vuillez; G Daniel; G Aillet; A Chetanneau; J Visset; M Kremer; P Thédrez; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.